Glaukos
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.About GKOS
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.
CEOThomas William Burns
CEOThomas William Burns
Employees995
Employees995
HeadquartersAliso Viejo, California
HeadquartersAliso Viejo, California
Founded1998
Founded1998
Employees995
Employees995
GKOS Key Statistics
Market cap5.58B
Market cap5.58B
Price-Earnings ratio-42.85
Price-Earnings ratio-42.85
Dividend yield—
Dividend yield—
Average volume764.09K
Average volume764.09K
High today$100.32
High today$100.32
Low today$97.70
Low today$97.70
Open price$99.82
Open price$99.82
Volume598.59K
Volume598.59K
52 Week high$163.71
52 Week high$163.71
52 Week low$77.10
52 Week low$77.10
GKOS News
Simply Wall St 5d
Breakeven On The Horizon For Glaukos CorporationWith the business potentially at an important milestone, we thought we'd take a closer look at Glaukos Corporation's ( ) future prospects. Glaukos Corporation,...
Analyst ratings
75%
of 16 ratingsBuy
75%
Hold
18.8%
Sell
6.3%
People also own
Based on the portfolios of people who own GKOS. This list is generated using Robinhood data, and it’s not a recommendation.